Table 1.
Mdm2-transgenic micea | Mdm2 transgenic/p53-null miceb | p53-null micec |
---|---|---|
14 Malignant lymphoma | 14 Malignant lymphoma | 35 Malignant lymphoma |
9 Hemangiosarcoma | 8 Hemangiosarcoma | 2 Osteosarcoma |
1 Rhabdomyosarcoma | 2 Osteosarcoma | 1 Rhabdomyosarcoma |
1 Adenocarcinoma | 1 Squamous cell carcinoma | 1 Undifferentiated sarcoma |
1 Pituitary adenoma | 1 Medulloblastoma | 3 Carcinomas |
10/26 Tumors = sarcomas (38%) | 10/26 Tumors = sarcomas (38%) | 4/42 Tumors = sarcomas (9%) |
Tumors isolated from 22 Mdm2-transgenic, p53 +/+ mice, 21 Mdm2-transgenic, p53 −/− mice were classified by histopathology. Numbers in parentheses represent the percentage of all tumors that are sarcomas.